Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the three and six months ended June 30, 2026, and 2025 (in thousands, except number of shares):


	Three months ended June 30,				Six months ended June 30,
	2026		2025		2026		2025
Numerator:
Net loss	$	(10,599)	$	(21,126)	$	(16,133)	$	(40,784)
Net loss attributable to noncontrolling interest	19		2		22		12
Net loss attributable to Barinthus Biotherapeutics plc shareholders	$	(10,580)	$	(21,124)	$	(16,111)	$	(40,772)
Denominator:
Weighted-average ordinary shares outstanding, basic	40,848,893		40,343,521		40,848,893		40,304,584

Weighted-average ordinary shares outstanding, diluted	40,848,893		40,343,521		40,848,893		40,304,584
Net loss per share attributable to ordinary shareholders, basic	$	(0.26)	$	(0.52)	$	(0.39)	$	(1.01)
Net loss per share attributable to ordinary shareholders, diluted	$	(0.26)	$	(0.52)	$	(0.39)	$	(1.01)